Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043085
Filing Date
2021-08-10
Accepted
2021-08-10 16:14:00
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-10q_20210630.htm   iXBRL 10-Q 2380220
2 EX-31.1 stsa-ex311_6.htm EX-31.1 21716
3 EX-31.2 stsa-ex312_9.htm EX-31.2 21474
4 EX-32.1 stsa-ex321_7.htm EX-32.1 9905
5 EX-32.2 stsa-ex322_8.htm EX-32.2 9829
  Complete submission text file 0001564590-21-043085.txt   6778900

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stsa-20210630.xsd EX-101.SCH 37308
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stsa-20210630_cal.xml EX-101.CAL 36403
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stsa-20210630_def.xml EX-101.DEF 98900
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20210630_lab.xml EX-101.LAB 299295
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20210630_pre.xml EX-101.PRE 210763
11 EXTRACTED XBRL INSTANCE DOCUMENT stsa-10q_20210630_htm.xml XML 1149938
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 211160042
SIC: 2834 Pharmaceutical Preparations